2019

1. Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program

   Clinical and Translational Oncology, Vol. 21, Núm. 9, pp. 1270-1279